<code id='D98DA0DCA2'></code><style id='D98DA0DCA2'></style>
      • <acronym id='D98DA0DCA2'></acronym>
      <center id='D98DA0DCA2'><center id='D98DA0DCA2'><tfoot id='D98DA0DCA2'></tfoot></center><abbr id='D98DA0DCA2'><dir id='D98DA0DCA2'><tfoot id='D98DA0DCA2'></tfoot><noframes id='D98DA0DCA2'>
      • <optgroup id='D98DA0DCA2'><strike id='D98DA0DCA2'><sup id='D98DA0DCA2'></sup></strike><code id='D98DA0DCA2'></code></optgroup>
        5. <b id='D98DA0DCA2'><label id='D98DA0DCA2'><select id='D98DA0DCA2'><dt id='D98DA0DCA2'><span id='D98DA0DCA2'></span></dt></select></label></b><u id='D98DA0DCA2'></u>
          <i id='D98DA0DCA2'><strike id='D98DA0DCA2'><tt id='D98DA0DCA2'><pre id='D98DA0DCA2'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / comprehensive      
           
     
           
      
          comprehensive 
           
      
           
      
           
       2025-09-28 07:02:12 
   
      
           
      
           
                        
          comprehensive  
          
                                   
                 
                                      author：entertainment   
                                        
                                      
                                      Page View：9
                                  
                                    
          
                                   
          Adobe
          LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.
          The deal includes up to another $400 million in payments if certain milestones are met.
          advertisement
          Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          I was wrong about Geron's blood cancer drug. Now, is it a takeover target?
                                
                            
          Next article：  
                                      
                                          After affirmative action ruling, medical educators look to 'holistic review'
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles